Indogulf Cropsciences IPO is a bookbuilt issue of ₹200.00 crore. It combines a fresh issue of 1.44 crore shares aggregating to ₹160.00 crores and an offer for sale of 0.36 crore shares aggregating to ₹40.00 crores.
The IPO opens for subscription on June 26, 2025, and closes on June 30, 2025. The allotment is expected to be finalized on Tuesday, July 01, 2025. The price band for the IPO is set at ₹105 to ₹111 per share, and the minimum lot size for an application is 135 shares.
Company Summary
Incorporated in 1993, Indogulf Cropsciences Limited is engaged in manufacturing crop protection products, plant nutrients, and biologicals in India.
The company manufactured Spiromesifen technical with 96.5% purity in 2019 and is one of the first indigenous manufacturers of Pyrazosulfuron Ethyl technical with 97% purity in India.
The company operates four manufacturing facilities in Samba (Jammu & Kashmir) and Nathupur (Haryana), covering approximately twenty acres, including two sites in Nathupur and one in Barwasni, Haryana.
The company has a sales network across 22 states and 3 Union Territories in India, with 169 business partners, 5,772 distributors, and 129 partners in 34 countries worldwide.
The company’s flexible, multi-purpose facilities allow diverse product manufacturing, adapting to customer needs. Its competitive advantage is strengthened by high regulatory barriers in the agrochemical industry, including costs and complex approvals.
As of August 31, 2024, the company had 640 permanent employees.
Product portfolio
- Plant Nutrients: The company manufactures specialty fertilizers, bio-simulants, and performance products, including straight fertilizers and soil health products, to enhance soil fertility, stimulate root growth, and improve crop yields.
- Crop Protection Products: The company manufactures crop protection products, including insecticides, fungicides, herbicides, and bio-stimulants, designed to safeguard crops from pests, diseases, and weeds, ensuring healthy growth and productivity.
- Biologicals: The company offers biological products, including bio-stimulants and bio-fertilizers, to improve crop growth, nutrient uptake, stress tolerance, and overall sustainability, with products like Biogold, Indo Breeza, and Indo Mycoriza.
Company strength
- Diversified product portfolio and specialized products across all three verticals.
- Established distribution network in India and abroad.
- Backward-integrated manufacturing infrastructure.
- Strong R&D and product development capabilities.
- Experienced Promoters and a strong management team.
Company Financials
Period Ended | 31 Dec 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
Assets | 597.81 | 542.25 | 517.51 | 413.59 |
Revenue | 466.31 | 555.79 | 552.19 | 490.23 |
Profit After Tax | 21.68 | 28.23 | 22.42 | 26.36 |
EBITDA | 44.78 | 55.74 | 49.04 | 47.24 |
Net Worth | 265.43 | 231.65 | 203.25 | 180.51 |
Reserves and Surplus | 216.64 | 208.01 | 179.60 | 156.87 |
Total Borrowing | 206.30 | 154.56 | 189.22 | 101.38 |
Amount in ₹ Crore |
Objectives of IPO
Objects of the Issue | Expected amount (₹ in Crore) |
Funding working capital requirements of our company | 65.00 |
Repayment/ prepayment, in full or in part, of certain outstanding borrowings availed by our Company | 34.12 |
Capital expenditure of our Company for setting up an in-house dry flowable (DF) plant at Barwasni, District Sonipat, Haryana | 14.00 |
General Corporate Purposes | – |
Promoters of the company
Om Prakash Aggarwal, Sanjay Aggarwal, Anshu Aggarwal, and Arnav Aggarwal are the promoters of the company.
IPO Details
IPO Date | June 26, 2025 to June 30, 2025 |
Listing Date | July 03, 2025 |
Face Value | ₹10 per share |
Price Band | ₹105 to ₹111 per share |
Lot size | 135 shares |
Total Issue size | 1,80,18,017 shares (aggregating up to ₹200.00 Cr) |
Fresh issue | 1,44,14,414 shares (aggregating up to ₹160.00 Cr) |
Offer for Sale | 36,03,603 shares of ₹ 10 (aggregating up to ₹40.00 Cr) |
Issue type | Bookbuilding IPO |
Listing at | NSE, BSE |
Share Holding Pre Issue | 4,87,87,456 shares |
Share Holding Post Issue | 6,32,01,870 shares |
Lot Allocation Details
Application | Lots | Shares | Amount |
Retail (Min) | 1 | 135 | ₹14,985 |
Retail (Max) | 13 | 1755 | ₹1,94,805 |
S-HNI (Min) | 14 | 1890 | ₹2,09,790 |
S-HNI (Max) | 66 | 8910 | ₹9,89,010 |
B-HNI (Min) | 67 | 9045 | ₹10,03,995 |
Allotment schedule
Basis of Allotment | Yue, Jult 01, 2025 |
Initiation of Refunds | Wed, Jul 02, 2025 |
Credit of Shares to Demat | Wed, Jul 02, 2025 |
Tentative Listing Date | Thu, Jul 03, 2025 |
Cut-off time for UPI mandate confirmation | 5 PM on June 30, 2025 |
IPO Reservation
Investor Category | Shares Offered |
QIB Shares Offered | Not more than 50% of the Net Offer |
Retail Shares Offered | Not less than 35% of the Net Offer |
NII (HNI) Shares Offered | Not more than 15% of the Net Offer |
To check allotment, click here